Search Results 701-710 of 18367 for Hepatitis b

1. A Study to Evaluate the Safety, Tolerability, and Determine the Optimal Dose for the Expansion Cohorts of VSV-IFNβ-NIS in Combination with Pembrolizumab in Patients with Refractory Solid Tumors - Mayo Clinic

   Acute hepatitis B or acute hepatitis C. Patients with chronic hepatitis B or hepatitis C may be enrolled provided their liver function is adequate as per ...

2. Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma - Mayo Clinic

   Known active hepatitis B or C, or human immunodeficiency virus (HIV) infection; Subjects who, in the opinion of the Investigator, are unable or unlikely to ...

3. Study to Evaluate Safety and Tolerability of XmAb13676 in Patients With CD20-expressing Hematologic Malignancies - Mayo Clinic

   hepatitis B DNA testing is negative and the patient is receiving hepatitis B reactivation prophylaxis with entecavir, tenofovir, or lamivudine. Patient is ...

4. Study to Assess the Effectiveness and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone to Treat Patients with Previously Treated Non-Hodgkins Lymphoma - Mayo Clinic

   ... B‐Cell Lymphoma patients. Participation eligibility. Participant ... Evidence of chronic active Hepatitis B (HBV) as evidenced by a detectable hepatitis ...

5. A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer - Mayo Clinic

   * Patients with positive serology for hepatitis B (unless immune due to ... * Negative test for antibodies to hepatitis B surface antigens (anti-HBs).

6. To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients - Mayo Clinic

   Donor or recipient with known hepatitis C infection (Hepatitis C Virus (HCV) ... hepatitis B are not excluded by this criterion. Primary focal segmental ...

7. A Study Evaluating AMG 424 in Subjects With Multiple Myeloma - Mayo Clinic

   Positive for hepatitis B surface antigen (HepBsAg) (indicative of chronic hepatitis B or recent acute hepatitis B);; Negative HepBsAg and positive for hepatitis ...

8. Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome - Mayo Clinic

   ... hepatitis B (e.g. hepatitis B virus [HBV] surface antigen [HBsAg] reactive) or hepatitis C (e.g. hepatitis C virus [HCV] ribonucleic acid [RNA] [qualitative] ...

9. Mayo Clinic Podcast - Dr. Gregory Poland YouTube Audio Expor...

   Yeah, so now several of the vaccine manufacturers have done trials, and they're going to do them down to birth age, just like when we give hepatitis B vaccine ...

10. A Study to Evaluate ADP-A2M4 with Pembrolizumab to Treat Recurrent or Metastatic Head and Neck Cancer - Mayo Clinic

    Active hepatitis B infection as demonstrated by test for hepatitis B surface antigen. Subjects who are hepatitis B surface antigen negative but are hepatitis B ...